Injection Nirsevimab 50 mg/0.5 ml Vaccine PFS for Railway Board
Bid Value
—
Closing Date
24 June 2026
Days Remaining
6 days
AI Tender Synthesis
Pre-generatedThe mandatory requirement for the product to be on the manufacturing firm's approved product list of the Railway Board makes this tender highly restrictive and exclusionary for most potential bidders not already pre-qualified, limiting general applicability.
What's Being Procured
The Ministry of Railways is procuring Injection Nirsevimab 50 mg/0.5 ml vaccine in pre-filled syringes (PFS) with item code M280806. The key scope is the supply of this specific vaccine, with a crucial eligibility being the manufacturer's presence on the Railway Board's approved list.
Eligibility Criteria
- 01Technical: The product, Injection Nirsevimab 50 mg/0.5 ml vaccine PFS, must be available in the manufacturing firm's approved product list of the Railway Board.
Technical Scope
- 01Supply of Injection Nirsevimab 50 mg/0.5 ml vaccine in Pre-Filled Syringes (PFS)
- 02Adherence to item code M280806 specifications
Documents Required
None identified
Watch Out For
- Mandatory requirement for the manufacturing firm to be on the Railway Board's approved product list, which can severely limit competition and exclude most bidders not already pre-approved.
- Estimated value not specified, making the potential opportunity size unclear.
Bid Value
—
Summary
This tender is for the procurement of Injection Nirsevimab 50 mg/0.5 ml vaccine in pre-filled syringes (PFS). The specific item code is M280806. The procurement is being conducted by the Ministry of Railways. A crucial requirement for this tender is that the product must be available in the manufacturing firm's approved product list of the Railway Board. The bid submission deadline is June 24, 2026, at 01:30 PM.
Eligibility Requirements
The product, Injection Nirsevimab 50 mg/0.5 ml vaccine PFS, must be available in the manufacturing firm's approved product list of the Railway Board. This is a mandatory eligibility criterion.